Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ФРАКЦИЯ S9<.>)
Общее количество найденных документов : 28
Показаны документы с 1 по 20
 1-20    21-28 
1.
Wu Hepatic metabolism of three alpha-1-adrenergic receptor antagonists, RWJ-69205, RWJ-69471, and RWJ-69597 in the rat, dog, and human // Drug Metab. Rev., 2003. Vol. 35, прил. 2.-С.43

2.
Wu W.N. In vitro metabolism of the anxiolytic agent, RWJ53050, in rat and human hepatic S9 FR // ISMDO 98. -Montpellier, 1998.-С.27

3.
Wu W.N. In vitro metabolism of the analgesic agent, RWJ-51784, in rat, dog and human hepatic S9 Fr. // MDO 2000. -Torino, 2000.-С.158

4.
Species comparison of the in vitro metabolism of benzoporphyrin derivative (CL 318,952) in liver slices and subcellular fractions (hepatic S9 and microsomes) from the rat, dog and man // Photochem. and Photobiol., 1994. Vol. 59, Spec. Issue.-С.71-72

5.
Species comparison of the in vitro metabolism of benzoporphyrin derivative (CL 318,952) in liver slices and subcellular fractions (hepatic S9 and microsomes) from the rat, dog and man // Photochem. and Photobiol., 1994. Vol. 59, Spec. Issue.-С.71-72

6.
Sahasranaman S. Metabolism of mometasone furoate and biological activity of the metabolites // Drug Metab. and Dispos., 2006. Vol. 34, N 2.-С.225-233

7.
Pharmacokinetic analysis of a series of dianilinopyrimidine inhibitors of VEGER2 tyrosine kinase: Correlation of the in vitro and in vivo metabolic stability of a specific glucuronidation reaction and the discovery of GW2286 // Drug Metab. Rev., 2001. Vol. 33, прил. N 1.-С.243

8.
Pan masala - a genotoxic menace // Mutat. Res. Genet. Toxicol. Test., 1994. Vol. 320, N 3.-С.245-249

9.
Pan masala - a genotoxic menace // Mutat. Res. Genet. Toxicol. Test., 1994. Vol. 320, N 3.-С.245-249

10.
Mori* Involvement of microsomal cytochrome P-450 in the mutagenic activation of 9 carcinogenic N-nitrosopropylamine derivatives by liver S9 from 5 animal species and man // j. Pharmacobio-Dyn., 1989. Vol. 12, N 3.-С.S-79

11.
Metabolic activation of 2-aminoanthracene and benz(a)pyrene to mutagens by rat hepatic S9 fraction and by hepatocytes induced in vivo or in vitro // Drug Metab. Rev., 2003. Vol. 35, прил. 2.-С.228

12.
Liver microsomes and S9 from rainbow trout (Oncorhynchus mykiss): Comparison of basal-level enzyme activities with rat and determination of xenobiotic intrinsic clearance in support of bioaccumulation assessment // Environ. Toxicol. and Chem., 2009. Vol. 28, N 3.-С.481-488

13.
Liver microsomes and S9 from rainbow trout (Oncorhynchus mykiss): Comparison of basal-level enzyme activities with rat and determination of xenobiotic intrinsic clearance in support of bioaccumulation assessment // Environ. Toxicol. and Chem., 2009. Vol. 28, N 3.-С.481-488

14.
Ju Y.-H. Mutant spectra analysis at hisG46 in Salmonella typhimurium induced by mammalian S9- and plant-activated benzidine // Environ. and Mol. Mutagenes., 1995. Vol. 25, Suppl. n 25.-С.25

15.
Interspecies differences in pharmacokinetics and metabolism of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide: The role of N-acetyltransferase // Drug Metab. and Dispos., 2006. Vol. 34, N 2.-С.254-260

16.
In vitro mutagenicity and metabolism of the cycloaliphatic epoxy Cyracure{TM}UVR 6105 // Mutat. Res. Genet. Toxicol. and Environ. Mutagen., 2004. Vol. 563, N 1.-С.25-34

17.
In vitro metabolism of the neuropeptide antagonist, RWJ-58338, in rat and human hepatic S9 fractions // Drug Metab. Rev., 2002. Vol. 34, прил. 1.-С.80

18.
In vitro metabolism of the endocrine agents, RWJ-69678 and RWJ-69679 (Diastereomeric pair), in rat, dog and human hepatic S9 fractions // Drug Metab. Rev., 2002. Vol. 34, прил. 1.-С.80

19.
In vitro biotransformation of Navelbine in various species including man // Fundam. and Clin. Pharmacol., 1990. Vol. 4, N 4.-С.476

20.
In vitro and in vivo evaluation of the metabolism and bioavailability of ester prodrugs of MGS0039 (3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-decarboxylic acid), a potent metabotropic glutamate receptor antagonist // Drug Metab. and Dispos., 2006. Vol. 34, N 3.-С.369-374

 1-20    21-28 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)